Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is W  [Clear All Filters]
2023
Shi Y-S, Chen J-C, Lin B-H, Wang R-N, Zhao J, Li S, Zhang Y, Zhang X-F. Wall. and Its New Phytochemical, Pterosinsade A, Promote Hippocampal Neurogenesis Activating the Wnt Signaling Pathway. J Agric Food Chem. 2023.
Elsied MA, Sharawi ZW, Al-Amrah H, Hegazy RA, Mohamed AE, Saleh RM, El-Kholy SS, Farrag FA, Fayed MH, El-Magd MA. Walnut Kernel Oil and Defatted Extracts Enhance Mesenchymal Stem Cell Stemness and Delay Senescence. Molecules. 2023;28(17).
Gamit N, Dharmarajan A, Sethi G, Warrier S. Want of Wnt in Parkinson's disease: Could sFRP disrupt interplay between Nurr1 and Wnt signaling?. Biochem Pharmacol. 2023:115566.
Ghate PS, Vacharasin JM, Ward JA, Nowling D, Kay V, Cowen MH, Lawlor M-K, McCord M, Xu H, Carmona E, et al. The Warburg micro syndrome protein RAB3GAP1 modulates neuronal morphogenesis and interacts with axon elongation end ER-Golgi trafficking factors. Neurobiol Dis. 2023:106215.
Chan P, Rich JN, Kay SA. Watching the Clock in Glioblastoma. Neuro Oncol. 2023.
Mahdieh A, Yeganeh H, Motasadizadeh H, Nekoueifard E, Maghsoudian S, Ghahremani MHossein, Nyström B, Dinarvand R. Waterborne polyurethane magnetic nanomicelles with magnetically governed functions for breast cancer therapy. Int J Pharm. 2023:123356.
Anon. A way to wipe a cell's memory. Nature. 2023.
Cui G, Zhou J, Sun J, Kou X, Su Z, Xu Y, Liu T, Sun L, Li W, Wu X, et al. WD repeat domain 82 (Wdr82) facilitates mouse iPSCs generation by interfering mitochondrial oxidative phosphorylation and glycolysis. Cell Mol Life Sci. 2023;80(8):218.
Liu W, Xie A, Xiong J, Li S, Yang L, Liu W. WDR3 promotes stem cell-like properties in prostate cancer by inhibiting USF2-mediated transcription of RASSF1A. J Gene Med. 2023:e3498.
Han W-Y, Wang J, Zhao J, Zheng Y-M, Chai X-Q, Gao C, Bin Cai J-, Ke A-W, Fan J, Gao P-T, et al. WDR4/TRIM28 is a novel molecular target linked to lenvatinib resistance that helps retain the stem characteristics in hepatocellular carcinomas. Cancer Lett. 2023:216259.
Liu L, Fang Y, Ding X, Zhou W, Terranova R, Zhang Y, Wang H. Wdr5 is essential for fetal erythropoiesis and hematopoiesis. Exp Hematol Oncol. 2023;12(1):39.
Mitchell K, Sprowls SA, Arora S, Shakya S, Silver DJ, Goins CM, Wallace L, Roversi G, Schafer R, Kay K, et al. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma. Genes Dev. 2023.
Wood WA, Dilip D, Derkach A, Grover NS, Elemento O, Levine R, Thanarajasingam G, Batsis JA, Bailey C, Kannappan A, et al. Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2). PLOS Digit Health. 2023;2(1):e0000178.
Chen C-P, Yeh C-N, Pan Y-R, Huang W-K, Hsiao Y-T, Lo C-H, Wu C-E. Wee1 inhibition by MK1775 potentiates gemcitabine through accumulated replication stress leading to apoptosis in biliary tract cancer. Biomed Pharmacother. 2023;166:115389.
Madsen K, Lee K, Chen S, Chen C, Law ADatt, Gerbitz A, Kumar R, Kim D, Lam W, Pasic I, et al. Weight loss post-allogeneic stem cell transplant is associated with increased transplant-related mortality. Support Care Cancer. 2023;31(10):564.
Vos R, Bos S, Lindstedt S. Welcome to the club: Opening the door for club cell secretory protein as biomarker in lung transplantation. J Heart Lung Transplant. 2023.
Su Q, Yuan F, Li X, Wang X, Yang K, Shao L, Li W. Wfs1 loss-of-function disrupts the composition of mouse pancreatic endocrine cells from birth and impairs Glut2 localization to cytomembrane in pancreatic β cells. Biochem Biophys Res Commun. 2023;658:80-87.
Tai P, Chen X, Jia G, Chen G, Gong L, Cheng Y, Li Z, Wang H, Chen A, Zhang G, et al. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis. J Transl Med. 2023;21(1):823.
Aratikatla A, Maffulli N, Gupta M, Potti IA, Potty AG, Gupta A. Wharton's jelly and osteoarthritis of the knee. Br Med Bull. 2023.
Drobiova H, Sindhu S, Ahmad R, Haddad D, Al-Mulla F, Madhoun AAl. Wharton's jelly mesenchymal stem cells: a concise review of their secretome and prospective clinical applications. Front Cell Dev Biol. 2023;11:1211217.
Mokhtari T, Shayan M, Rashnudi ARezaei, Hassanzadeh G, Nia KMehran. Wharton's jelly mesenchymal stem cells attenuate global hypoxia-induced learning and memory impairment via preventing blood-brain barrier breakdown. Iran J Basic Med Sci. 2023;26(9):1053-1060.
Anon. Wharton's Jelly-Mesenchymal Stem Cell-Engineered Conduit for Pediatric Translation in Heart Defect, by Iacobazzi, et al. Tissue Engineering Part A 2021;27(3-4):201-213; doi: 10.1089/ten.tea.2020.0088. Tissue Eng Part A. 2023.
Cytryn R, Bickell N, Yagnik R, Jagannath S, Lin JJ. What Affects Treatment Underuse in Multiple Myeloma in the United States: A Qualitative Study. Cancers (Basel). 2023;15(8).
Chandhanayingyong C, Thanapipatsiri P, Pairojboriboon S, Luenam S, Hongsaprabhas C, Charoenlap C, Wattanapaiboon K, Asavamongkolkul A, Tharmviboonsri T, Phimolsarnti R. What Are the MSTS Scores and Complications Associated With the Use of Three-dimensional Printed, Custom-made Prostheses in Patients Who Had Resection of Tumors of the Hand and Foot?. Clin Orthop Relat Res. 2023.

Pages